New contact lenses that deliver allergy medication for itchy eyes
Drug delivery platform for ocular allergy therapy
This study is testing a new type of contact lens that releases allergy medicine directly to your eyes, making it easier and more comfortable for people with itchy eyes from allergies to find relief without using eye drops all the time.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lynthera Corporation NIH-funded |
| Lab location | 1 site (Lancaster, United States) |
| Project ID | NIH-10922084 on NIH RePORTER |
What this research studies
This research focuses on developing a next-generation contact lens that delivers the allergy medication olopatadine directly to the eyes. It aims to improve the comfort and effectiveness of allergy treatment for contact lens wearers who suffer from itchy eyes due to allergic conjunctivitis. The approach involves using innovative drug delivery technology to control the release of the medication, enhancing its efficacy while maintaining lens breathability. Patients will benefit from a more convenient and effective way to manage their allergy symptoms without the need for frequent eye drops.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who wear contact lenses and experience symptoms of allergic conjunctivitis.
Not a fit: Patients who do not wear contact lenses or do not suffer from allergic conjunctivitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and convenient treatment option for patients suffering from ocular allergies.
How similar studies have performed: Other research has shown success with similar drug delivery approaches in contact lenses, indicating a promising avenue for allergy treatment.
Where this research is happening
Lancaster, United States
- Lynthera Corporation — Lancaster, United States (Active)
Researchers
- Principal investigator: Yang, Arthur — Lynthera Corporation
- Study coordinator: Yang, Arthur
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.